France · Advertising framework
Television advertising for medical devices in France
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Medical-device claims must match the assessed purpose
Legal requirement — paraphrased
Applies when: The advertised product or software function is a medical device under the MDR.
For a regulated medical device, Article 7 prohibits misleading text, names and images, including unsupported functions, a false impression of treatment or diagnosis, omission of likely risks, and uses outside the purpose assessed for conformity. This includes software when it meets the medical-device definition.
Reimbursement and risk lists affect public device advertising
Legal requirement — paraphrased
Applies when: The offer is a medical device or accessory within CSP L5213; diagnostic IVDs require their own local provisions.
Public advertising of reimbursed devices and accessories is restricted, with a low-risk exception defined by the applicable list. Certain higher-risk devices require ANSM prior authorisation. Review the exact class, reimbursement status, current lists and device-specific requirements before choosing a public channel.
Check the audience-specific prior-authorisation list
Regulator guidance
The amended device list places public advertising for dermal filling products under prior ANSM authorisation. Its professional-audience list is broader, including specified cardiac implants, breast and joint implants, intraocular lenses and surgical lasers. Do not infer that a device absent from one audience list is freely advertisable: reimbursement restrictions, intended users and product claims remain separate tests.
Channel rules
Check the complete consumer-facing message
Regulator guidance
The EU consumer-protection framework addresses misleading actions and omissions, including an overall deceptive presentation and undisclosed commercial intent. Review benefits, risks, qualifications and prices as a whole under the national implementing law. Space limits do not provide an automatic exemption from material information requirements.
Sources: EU Unfair Commercial Practices Directive 2005/29/EC
Review the broadcast execution
Editorial recommendation
Confirm product eligibility for public broadcast and the applicable broadcaster code and clearance process. Review warning timing, speech and image together; internet-video approval does not automatically cover television.
Campaign workflow
Medical Devices & Medtech: prepare the review
Editorial recommendation
Identify the device, intended purpose, risk class and intended users. Check local market status and any advertising review or public-promotion restriction. Use performance evidence for the advertised model and purpose; distinguish registration from approval.
Keep a traceable campaign decision
Editorial recommendation
Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.
Pre-publication checklist
- Identify the device, intended purpose, risk class and intended users.
- Check local market status and any advertising review or public-promotion restriction.
- Use performance evidence for the advertised model and purpose; distinguish registration from approval.
- Record product or provider eligibility before approving claims.
- Archive the final creative and its evidence, permissions and review decisions.
- Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.
Scope and unresolved questions
- Dental communication, the March 2026 pharmacy code and device/IVD authorisation-list routes are now documented. Still verify the exact product classification, reimbursement, current ANSM decision and filing window, other professional codes and the actual influencer arrangement. The March 2026 visa form is evidence of that filing period, not confirmation of later filing dates.
- This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates
A medical-device campaign in television campaigns in France depends on the intended purpose, users and local regulatory status of the advertised model. Review those facts before turning performance evidence into a consumer-facing promise.
For television, assess both the creative and the broadcaster's classification of the placement. Presenter choice, voiceover, warning panels and cut-down versions need to work within the same execution; sponsorship and product placement have their own conditions.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
How to use this national baseline
Editorial overview
This framework combines researched national rules with editorial review steps. French health-product and professional communication baseline plus EU requirements. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.
The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.
Sources
- EU Medical Devices Regulation 2017/745
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Code de la santé publique: dispositifs médicaux
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- EU Unfair Commercial Practices Directive 2005/29/EC
EU framework implemented through national law; sector rules and local implementation also apply.
- Device advertising prior-authorisation list
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
From framework to action
Local expertise in France
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in France.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
No partners listed in this category yet.
Business & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.